HAVCR1 and acute kidney injury: They found that KIM-1 was elevated at diagnosis but decreased after induction of remission therapy, suggesting that KIM-1 may be a biomarker of acute kidney injury (AKI) and tubulointerstitial damage in ANCA-GN.